Prevention of late renal changes after initial, ischemia/reperfusion injury by blocking early selectin binding

Transplantation

Volumn 64, Issue 11, 1997, Pages 1520-1525

  Takada, Moriatsu ^a   Nadeau, Kari C ^b   Shaw, Gray D ^c   Tilney, Nicholas L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 6; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; SELECTIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOLOGY; KIDNEY ALLOGRAFT; KIDNEY ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE INJURY;

ANIMALS; CHEMOKINE CCL2; ENDOTHELIN-1; INTERLEUKIN-6; ISCHEMIA; KIDNEY; LIGANDS; MALE; MEMBRANE GLYCOPROTEINS; MUCINS; P-SELECTIN; POLYMERASE CHAIN REACTION; PROTEINURIA; RATS; RATS, INBRED LEW; REPERFUSION INJURY; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031458014     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199712150-00003     Document Type: Article

References (49)

1. Gjertson DW. Survival trends in long-term first cadaver-donor kidney transplants. In: Terasaki PI, Cecka JM, eds. Clinical transplants 1991. Los Angeles: UCLA Tissue Typing Laboratory, 1992: 225.
2. Naimark DMJ, Cole E. Determinants of long-term renal allograft survival. Transplant Rev 1994; 3: 93.
3. Pirsch JD, Pleog RJ, Grange S, et al. Determinants of graft survival after renal transplantation. Transplantation 1996; 61: 1581.
4. Goes N, Urmson J, Ramassar V, Halloran PF. Ischemic acute tubular necrosis induces an extensive local cytokine response. Transplantation 1995; 59: 565.
5. Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NL. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney: inhibition by a soluble P-selectin ligand. J Clin Invest 1997; 99: 2682.
6. Weyrich AS, Ma X-L, Lefer DJ, Albertine KH, Lefer AM. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993; 91: 2620.
7. Rice GE, Bevilacqua MP. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 1989; 246: 1303.
8. Weller A, Isenmann S, Vestweber D. Cloning of the mouse endothelial selectins: expression of both E- and P-selectin is inducible by tumor necrosis factor alpha. J Biol Chem 1992; 267: 15176.
9. Kaufman RJ, Davies MV, Wasley LC, Michnick D. Improved vectors for stable expression of foreign genes in mammalian cells by use of the untranslated leader sequence from EMC virus. Nucleic Acids Res 1991; 19: 4485.
10. Kukowska-Latallo JF, Larsen RD, Nair RP, Lowe JB. A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group alpha (1,3/1,4) fucosyltransferase. Genes Devel 1990; 4: 1288.
11. Bierhuizen MFA, Fukuda M. Expression cloning of a cDNA encoding UDP-GlcNAc: Gal beta 1-3-GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen. Proc Natl Acad Sci USA 1993; 89: 9326.
12. Sako D, Comess KM, Barone KM, Camphausen RT, Cumming DA, Shaw GD. A sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding. Cell 1995; 83: 323.
13. Diamond JR, Tilney NL, Frye J, et al. Progressive albuminuria and glomerulosclerosis in a rat model of chronic renal allograft rejection. Transplantation 1992; 54: 710.
14. Davidson L, Henry JB. Clinical diagnosis by laboratory methods, 14th ed. Philadelphia: W.B. Saunders, 1969: 48.
15. + T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin. J Immunol 1987; 138: 164.
16. Reinke P, Fietze E, Döcke WD, Kern F, Ewert R, Volk H-D. Late acute rejection in long-term renal allograft recipients. Transplantation. 1994; 58: 35.
17. Platzer C, Ode-Hakim S, Reike P, Döcke W-D, Ewert R, Volk H-D. Quantitative PCR analysis of cytokine transcription patterns in peripheral mononuclear cells after anti-CD3 rejection therapy using two novel multispecific competitor fragments. Transplantation 1994; 58: 264.
18. Volk H-D, Müller S, Yarkoni S, Diamantstein T, Lorberboum-Galski H. Mechanisms of dichotomous action of IL-2-Pseudomonas exotoxin 40 (IL-2-PE40) on cell-mediated and humoral immune response. J Immunol 1994; 153: 2497.
19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanitidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156.
20. Nadeau KC, Azuma H, Tilney NL. Cytokine expression in chronic rejection: role for MCP-1 and RANTES. Proc Natl Acad Sci USA 1995; 92: 8729.
21. Carpenter CB. Long-term failure of renal transplants: adding insult to injury. Kidney Int 1995; 48: s40.
22. Almond PS, Matas A, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
23. Ley K, Tedder TF. Leukocyte interactions with vascular endothelium. J Immunol 1995; 155; 525.
24. McEver RP, Moor KL, Cummings RD. Leukocyte trafficking mediated by selectin carbohydrate interactions. J Biol Chem 1995; 270: 11025.
25. Sako D, Chang X-J, Barone KM, et al. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 1993; 75: 1179.
26. Turunen JP, Paavonen T, Majuri M-L, et al. Sialyl Lewis X- and L-selectin-dependent site-specific lymphocyte extravasation into renal transplants during acute rejection. Eur J Immunol 1994; 24: 1130.
27. Han KT, Sharar SR, Phillips ML, Harlan JM, Winn RK. Sialyl LewisX oligosaccharide reduces ischemia-reperfusion injury in the rabbit ear. J Immunol 1995; 155: 4011.
28. Garcia-Criado FJ, Toledo-Pereyra LH, Lopez-Neblina F, Phillips ML, Paez-Rollys A, Misawa K. Role of P-selectin in total hepatic ischemia and reperfusion. J Am Coll Surg 1995; 181: 327.
29. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury: modulating effects of FK506 and cyclosporine. Transplantation 1993; 55: 1265.
30. Picker LJ, Warnock RA, Burns AR, Doerschuk CM, Berg EL, Butcher EC. The neutrophil selectin LECAM-1 presents carbohydrate ligands to the vascular selecting ELAM-1 and GMP-140. Cell 1991; 66: 921.
31. Moore KL, Eaton SF, Lyons DE, Lichenstein HS, Cummings RD, McEver RP. The P-selectin glycoprotein ligand from human neutrophils displays sialylated, fucosylated, O-linked poly-N-acetyllactosamine. J Biol Chem 1994; 269: 23318.
32. Asa D, Raycroft L, Ma L, et al. The P-selectin glycoprotein ligand functions as a common human leukocyte ligand for P- and E-selectins. J Biol Chem 1995; 270: 11662.
33. Spertini O, Cordey AS, Monai N, Giuffrè L, Scapira M. P-selectin glycoprotein ligand 1 is a ligand for L-selectin on neutrophils, monocytes, and CD34+ hematopoietic progenitor cells. J Cell Biol 1996; 135: 523.
34. Guyer DA, Moore KL, Lynam EB, et al. P-selectin glycoprotein ligand-1 (PSGL-1) is a ligand for L-selectin in neutrophil aggregation. Blood 1996; 88: 2415.
35. Pinsky DJ, Naka Y, Liao H, et al. Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. J Clin Invest 1996; 97: 493.
36. Gotsch U, Jager U, Dominis M, Vestweber D. Expression of P-selectin on endothelial cells is upregulated by LPS and TNF-alpha in vivo. Cell Adhesion Commun 1994; 2: 7.
37. Bischoff J, Brasel C. Regulation of P-selectin by tumor necrosis factor-alpha. Biochem Biophys Res Commun 1995; 210: 174.
38. Khew-Goodall Y, Butcher CM, Litwin MS, et al. Chronic expression of P-selectin on endothelial cells stimulated by the T-cell cytokine, interleukin-3. Blood 1996; 87: 1432.
39. Sako D, Comess KM, Barone KM, Camphausen RT, Cumming DA, Shaw GD. A sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding. Cell 1995; 83: 323.
40. Vachino G, Chang X-J, Veldman GM, et al. P-selectin glycoprotein ligand-1 is the major counter-receptor for P-selectin on stimulated T cells and is widely distributed in non-functional form on many lymphocytic cells. J Biol Chem 1995; 270: 21966.
41. Ferrario RG, Foulkes R, Salvati P, Pattrono C. Hemodynamic and tubular effects of endothelin and thromboxane in the isolate perfused rat kidney. Eur J Pharmacol 1989; 171: 127.
42. Cozza EN, Gomez-Sanchez CE. Effects of endothelin-1 on its receptor concentration and thymidine incorporation in calf adrenal zona glomerulosa cells. Endocrinology 1990; 127: 549.
43. McMillen MA, Huribal M, Cunningham ME, et al. Endothelin-1 increases intracellular calcium in human monocytes and causes production of interleukin-6. Crit Care Med 1995; 280: 103.
44. Troppmann C, Gillingham KJ, Benedetti E, et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. Transplantation 1995; 59: 962.
45. Troppman C, Gillingham KJ, Gruessner RWG, et al. Delayed graft function in the absence of rejection has no long-term impact. Transplantation 1996; 61: 1331.
46. Heil J, Sutherland DER, Najarian JS, et al. Acute tubular necrosis of cadaveric renal allografts does not correlate with organ sharing or preservation time but portends a poorer prognosis for long-term graft survival. Transplant Proc 1983; 16: 270.
47. Brenner BM, Milford EL. Nephron underdosing: a programmed cause of chronic renal allograft failure. Am J Kidney Dis 1993; 21: 66.
48. Chertow GM, Milford EL, Mackenzie HS, et al. Antigen-independent determinants of cadaver kidney transplant failure. J Am Med Assoc 1997; 276: 1732.
49. Azuma H, Nadeau KC, Mackenzie H, Brenner BM, Tilney NL. Nephron mass modulates the hemodynamic, cellular, and molecular response of the rat renal allograft. Transplantation 1997; 63: 519.